5461
|
|
|
Glutamate ionotropic receptor delta type subunit 2 |
GluD2, SCAR18 |
Spinocerebellar ataxia, Attention deficit hyperactivity disorder, Autism, Congenital cerebellar ataxia, Cardiomyopathy, Central nervous system cancer, Glioblastoma, Glioma, Metabolic syndrome, Non-melanoma skin carcinoma, Obesity, Obsessive-compulsive disorder, Osteoarthritis, Peripheral neuropathy, Schizophrenia, Hypertension, Diabetes mellitus type 2View all (2 more) |
5462
|
|
|
Grid2 interacting protein |
DELPHILIN |
|
5463
|
|
|
Galectin-related inter-fiber protein |
- |
|
5464
|
|
|
Glutamate ionotropic receptor kainate type subunit 1 |
EAA3, EEA3, GLR5, GLUR5, GluK1, gluR-5 |
Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Breast cancer, Eosinophilia, Hepatocellular carcinoma, Lung cancer, Major depressive disorder, Ocular hypertension, Osteonecrosis, Periodontitis, Schizophrenia, Scoliosis, Seizures, Squamous cell carcinoma, Stroke, Substance abuse, Upper aerodigestive tract neoplasmView all (4 more) |
5465
|
|
|
Glutamate ionotropic receptor kainate type subunit 2 |
EAA4, GLR6, GLUK6, GLUR6, GluK2, MRT6, NEDLAS |
Alzheimer disease, Autism, Nonsyndromic intellectual disability, Bell's palsy, Bipolar disorder, Breast neoplasms, Non-small-cell lung carcinoma, Carotid artery disease, Central nervous system cancer, Cerebral amyloid angiopathy, Colorectal cancer, Colonic neoplasms, Color vision deficiency, Neurodevelopmental disorder, Dementia, Bipolar depression, Endometriosis, Esophageal neoplasms, Glaucoma, Glioblastoma, Glioma, Huntington disease, Inflammatory bowel disease, Insomnia, Intellectual developmental disorder, Irritable bowel syndrome, Liver neoplasms, Lymphatic metastasis, Major depressive disorder, Mood disorder, Nervous system disease, Non-specific syndromic intellectual disability, Obesity, Obsessive-compulsive disorder, Ovarian neoplasms, Schizophrenia, Scoliosis, Hypertension, Vascular dementiaView all (24 more) |
5466
|
|
|
Glutamate ionotropic receptor kainate type subunit 3 |
EAA5, GLR7, GLUR7, GluK3, GluR7a |
Alzheimer disease, Anorexia nervosa, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Dementia, Major depressive disorder, Endometriosis, Hypertension, Insomnia, Neurotic disorder, Non-small cell lung carcinoma, Obesity, Obsessive-compulsive disorder, Psychotic disorders, Willis-ekbom disease, Schizophrenia, Scoliosis, Small cell lung carcinoma, Tourette syndromeView all (5 more) |
5467
|
|
|
Glutamate ionotropic receptor kainate type subunit 4 |
EAA1, GRIK, GluK4, GluK4-2, KA1 |
Appendicitis, Attention deficit hyperactivity disorder, Behcet disease, Bipolar disorder, Coronary artery disease, Bipolar depression, Idiopathic pulmonary fibrosis, Major depressive disorder, Non-organic psychosis, Psychotic disorders, Schizophrenia, Small vessel stroke, Depression |
5468
|
|
|
Glutamate ionotropic receptor kainate type subunit 5 |
EAA2, GRIK2, GluK5, KA2 |
|
5469
|
|
|
Glutamate ionotropic receptor NMDA type subunit 1 |
DEE101, GluN1, MRD8, NDHMSD, NDHMSR, NMD-R1, NMDA1, NMDAR1, NR1, hNR1 |
Autism, Nonsyndromic intellectual disability, Bilateral generalized polymicrogyria, Bipolar disorder, Ischemic stroke, Neurodevelopmental disorder, Developmental and epileptic encephalopathy, Rolandic epilepsy, Hemimegalencephaly, Hyperalgesia, Intellectual developmental disorder, Non-specific syndromic intellectual disability, Psychotic disorders, Trigeminal neuralgia |
5470
|
|
|
Glutamate ionotropic receptor NMDA type subunit 2A |
EPND, FESD, GluN2A, LKS, NMDAR2A, NR2A |
Anorexia nervosa, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Kidney disease, Colorectal neoplasms, Neurodevelopmental disorder, Continuous spike and wave during slow wave sleep syndrome, Continuous spike and wave during sleep syndrome, Vascular dementia, Bipolar depression, Major depressive disorder, Developmental and epileptic encephalopathy, Partial epilepsy, Epilepsy, Familial temporal lobe epilepsy, Focal epilepsy with speech disorder and impaired intellectual development, Pyridoxine dependent epilepsy, Rolandic epilepsy, Global developmental delay, Huntington disease, Hypertension, Intellectual developmental disorder, Language development disorders, Melanoma, Mood disorder, Non-specific syndromic intellectual disability, Obsessive-compulsive disorder, Schizophrenia, Scoliosis, Substance abuse, Tourette syndromeView all (17 more) |